Phase II/III trial of hyperimmune anti-COVID-19 intravenous immunoglobulin (C-IVIG) therapy in severe COVID-19 patients: study protocol for a randomized controlled trialArticle Published on 2022-11-082022-11-16 Journal: Trials [Category] SARS, 변종, [키워드] adaptive anti-COVID-19 IVIG antivirals clinical evidence clinical trial collected convalescent convalescent plasma COVID-19 cumulative death Efficacy eligibility criteria evaluate Health hyperimmune immunization immunomodulators intravenous Intravenous immunoglobulin low dose monoclonal antibodies Neutralizing non-specific novel Novel coronavirus outcome Passive passive immunization Patient phase Pneumonia polyclonal polyclonal antibodies Pooled convalescent plasma Potential treatment Randomized Randomized controlled trial receive Recovered COVID-19 patients reported SARS CoV-2 SARS-CoV-2 sealed Secondary outcomes severe COVID-19 severe COVID-19 patient severe COVID-19 patients Standard of care Steroids Study protocol therapeutic option therapy treat Treatment Trial variant variants of concern virus virus particles World Health Organization [DOI] 10.1186/s13063-022-06860-2 PMC 바로가기
Decontamination Assessment of Nanofiber-based N95 MasksArticle Published on 2022-11-012022-11-16 Journal: Environmental science and pollution research inter [Category] 변종, [키워드] addition Aerosols assessment caused changes in decontamination dropped Efficiency electron microscopy emission equipment examined face Face masks Face masks, nanofibers field filtration filtration efficiency Health include management Mask Masks Microstructure morphological change morphology N95 mask N95 masks Novel coronavirus outbreak Pandemics Particle Personal protective equipment PPE pressure Pressure drop. reduction in Region scanning significantly Spread survivor ultraviolet UV light variant virus [DOI] 10.1007/s11356-022-20903-w PMC 바로가기
COVID-19 Australia: Epidemiology Report 66 Reporting period ending 25 September 2022Article Published on 2022-10-252023-07-10 Journal: Communicable diseases intelligence (2018) [Category] COVID19(2023년), [키워드] 2019-nCoV acute respiratory disease Australia Coronavirus disease 2019 COVID-19 Epidemiology Novel coronavirus SARS-CoV-2 [DOI] 10.33321/cdi.2022.46.73
Analysis of the mutation dynamics of SARS-CoV-2 genome in the samples from Georgia State of the United States미국 조지아주 샘플에서 SARS-CoV-2 게놈의 돌연변이 역학 분석Article Published on 2022-10-202022-09-11 Journal: Gene [Category] COVID19(2023년), SARS, 변종, 치료기술, [키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Algorithm Amino acid Analysis caused China clade clades Complete coronavirus disease Coronavirus disease 2019 Coronavirus-2 country Course COVID-19 D614G determine disease England Europe Filter Genome genome sequence Genome sequences Host indicate limit majority Multiple Multiple studies mutated Mutation N501Y NCBI database Novel coronavirus novel coronavirus SARS-CoV-2 nucleotide nucleotides online tool over P681H pandemic Phylogenetic Quality control reference genome SARS-CoV-2 SARS-CoV-2 genome SARS-CoV2 sequence Sequence alignment sequenced genomes sequences severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus-2 Spread state survival the United State the WHO translation Transmission variant variants virus was used Wuhan [DOI] 10.1016/j.gene.2022.146774 PMC 바로가기 [Article Type] Article
Learning from the COVID-19 pandemic for future epidemics and pandemics preparedness and response in Guinea: Findings from a scoping reviewArticle Published on 2022-10-172022-11-16 Journal: Frontiers in Public Health [Category] COVID19(2023년), SARS, 변종, [키워드] activities Analysis anticipated applied boost conducted counterproductive country COVID-19 COVID-19 pandemic database distress Epidemic Epidemics epidemiological finding FIVE generate globe Guinea health system health system preparedness and response implementation IMPROVE information learning measure Measures mechanism media National Novel coronavirus outbreak pandemic Pandemics policy decisions provide Research Resilience responses SARS-CoV-2 These data triggered vaccination variant [DOI] 10.3389/fpubh.2022.879850 PMC 바로가기
Performing under Pressure: Insights into the Diagnostic Testing Burden at a UK National Health Service Clinical Virology Laboratory during the SARS-CoV-2 PandemicArticle Published on 2022-10-122022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 치료기술, [키워드] burden clinical clinical sample COVID-19 Department detect diagnostics dramatic increase genomic Host immune response increase in information insight Laboratory Logistic maintain National Health Service NHS NHS laboratories NHS laboratory non-SARS-CoV-2 Novel coronavirus pandemic Performing routine SARS-CoV-2 SARS-CoV-2 testing Testing the SARS-CoV-2 viral infection Virology virus [DOI] 10.3390/v14102233 PMC 바로가기
Development of a low-cost multi-channel nucleic acid detection PCR instrument and clinical detection application of COVID-19Article Published on 2022-10-092022-11-15 Journal: Analytica chimica acta [Category] COVID19(2023년), SARS, 치료기술, [키워드] amplification COVID-19 COVID-19 outbreak development disadvantage Double channel experiment hospital Low-cost novel Novel coronavirus Nucleic acid detection optical PCR Quantitative quantitative PCR quantitative PCR instrument Real-time fluorescence quantitative PCR. variety were used [DOI] 10.1016/j.aca.2022.340338 PMC 바로가기
Association of Trends in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Seroprevalence and State-Issued Nonpharmaceutical Interventions: United States, 1 August 2020 to 30 March 2021Article Published on 2022-10-032022-11-15 Journal: Clinical Infectious Diseases: An Official Publicat [Category] COVID19(2023년), SARS, 진단, [키워드] 95% confidence interval acute respiratory syndrome anti-N antibody association Blood coronavirus coronavirus 2 COVID-19 COVID-19 incidence cumulative Donor effective individual Infection infections Mask mandates Mortality Multiple multivariable logistic regression nonpharmaceutical intervention Nonpharmaceutical interventions Novel coronavirus NPI NPIs reduced respiratory SARS-CoV-2 SARS-CoV-2 seroprevalence Seroprevalence Serosurvey trend United States vaccination [DOI] 10.1093/cid/ciac469 PMC 바로가기
A Review of Extracorporeal Blood Purification Techniques for the Treatment of Critically Ill Coronavirus Disease 2019 PatientsArticle Published on 2022-10-012022-11-15 Journal: ASAIO journal (American Society for Artificial Int [Category] COVID19(2023년), SARS, 치료제, [키워드] acute respiratory distress acute respiratory syndrome Antiviral apheresis Blood Blood purification caused characterized coronavirus coronavirus disease COVID-19 COVID-19 patients Critically ill Critically ill patient develop drug dysregulated immune response EBP Emergency use Extracorporeal extracorporeal blood purification food highlight host response Ill immune dysregulation Immunomodulatory therapies infected with SARS-CoV-2 Infection Multisystem organ failure novel Betacoronavirus Novel coronavirus outcome pandemic Patient reduce Respiratory illness review SARS-CoV-2 Seraph Spread syndrome System technique the disease the United State with COVID-19 World Health Organization Wuhan, China [DOI] 10.1097/MAT.0000000000001761 PMC 바로가기
Recent clinical findings on the role of kinase inhibitors in COVID-19 managementCOVID-19 관리에서 키나제 억제제의 역할에 대한 최근 임상 결과Review Published on 2022-10-012022-09-11 Journal: Life sciences [Category] 변종, 신약개발, 임상, 치료제, [키워드] activator affected alleviate Anti-inflammatory anti-viral effects antiviral agent Antiviral agents BTK clinical evidence Clinical finding Clinical practice clinical trial Complication complications Consequences coronavirus disease COVID-19 COVID-19 patient COVID-19 patients CRS cytokine release storm drug Efficacy glycogen synthase GSK-3 highly pathogenic inhibitor inhibitors JAK/STAT janus Janus kinase kinase Kinase inhibitor kinase inhibitors kinases management MAPK Novel coronavirus novel coronavirus disease outbreak p38 MAPK pandemic paradigm shift performed pharmacological pharmacological intervention protein kinase recent Signaling STAT therapy Transcription trials Viral load [DOI] 10.1016/j.lfs.2022.120809 PMC 바로가기 [Article Type] Review